Mar 30, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry
its use in women will be somewhat minimal,” Butler said.
Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ...
UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a
relatively high rate of genital infections which will limit uptake in our ...
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.
Mar 29, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with
type 2 diabetes in a new way, by causing blood sugar to be ...
Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to
... And it's true that diabetes patients often have to change meds to keep control of
... J&J wins first FDA approval for new class of diabetes drug
Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the
first in its class to be approved in the United States. The U.S. ...
Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, ... "We
wanted to hedge our bets to make sure we would win in this space ... Further
testing may be needed before the product can be approved by regulators. ....
Does anyone for a second think that ANY socialized medicine nation or ...
Oct 14, 2016 ... Most type 2 diabetes drugs manipulate insulin levels, which could lead to
complications ... Johnson & Johnson, the manufacturer of Invokana, received
approval for the drug from the FDA in 2013. ... How does Invokana work? ... It's
important to keep track of your blood sugar levels and know the symptoms of ....
Mar 29, 2013 ... Jardiance Wins CV Prevention Indication ... The drug is the only compound
approved for diabetes that does not have an effect on insulin. ... However,
drugmaker Janssen Pharmaceuticals, a Johnson & Johnson company, will have
to conduct ... in patients who have increased ketones in their blood or urine.
Apr 17, 2014 ... Johnson and Johnson's (JNJ) sales grew 3.5% in the past year, but only because
... Diabetes • Invokana – The first SGLT2 inhibitor to win FDA approval, ....
Johnson's investors will need to keep close tabs on these 3 drugs this year. ...
Merck, Pfizer, and Eli Lilly are also conducting phase 3 trials of their ow...